Format

Send to

Choose Destination
Int J Clin Pharmacol Ther. 2002 Dec;40(12):580-1.

Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors.

Author information

1
University of Essen, West German Cancer Center, Essen, Germany. dirk.strumberg@uni-essen.de
PMID:
12503822
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center